Live webinar | Online

Join a 75-minute expert-led webinar examining the clinical, regulatory and practical considerations involved in introducing a biosimilar into Multiple Sclerosis (MS) care in Belgium.

The programme will combine Belgian healthcare perspectives with experience from France and practical insights into MS-centre workflows. Participants will also have the opportunity to discuss implementation questions during an extended panel discussion and Q&A.

About the webinar

With the expected introduction of a biosimilar treatment option in Belgian MS care, neurologists need clear and independent education on how biosimilars are assessed, approved and implemented.

This webinar will address the regulatory principles and clinical evidence supporting biosimilars, including how they differ from generics. It will also consider how international experience may inform decision-making in Belgium.

The faculty will discuss practical implementation in daily MS care, including communication with people living with MS, shared decision-making, infusion-centre pathways, multidisciplinary coordination and monitoring procedures.

Learning objectives

By the end of the webinar, participants will be able to:

• Explain the regulatory framework for biosimilars and how biosimilars differ from generics.
• Relate experience from the introduction of a biosimilar in France to the Belgian context.
• Discuss practical approaches to patient communication, infusion pathways and monitoring when implementing biosimilars in MS care.
• Support informed discussion about biosimilars with multidisciplinary care teams and people living with Multiple Sclerosis.
• Consider the practical implications of biosimilar implementation for MS-centre workflows.

Who should attend?

This webinar is intended for:

• Clinically active neurologists based in Belgium
• Multiple Sclerosis specialists
• Neurology residents and trainees
• MS nurses and other healthcare professionals involved in multidisciplinary MS care

The webinar will be submitted for accreditation to the relevant Belgian authorities.

Recording

The webinar recording is expected to be published on the ParadigMS educational platform following the live session. Access will be restricted to healthcare professionals.

Registration

This session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions! 

Language

The session will be held in English with translated auto-captions into many languages (offered by Zoom platform).

Find out more about the speakers:

Prof. Bart Van Wijmeersch

Chair and moderator

Neurologist and Medical Director at the Rehabilitation & MS Center in Pelt, Belgium, and Associate Professor at Hasselt University.

Dr Serena Borrelli

Speaker

Neurologist and Medical Doctor at Univertsité Libre de Bruxelles, Belgium

Prof. Jérôme de Sèze

Speaker

Neurologist at Strasbourg University Hospitals and Head of the MS Expert Centre / CRC SEP in France.

Piet Eelen, RN, MSc

Speaker

Clinical Nurse Specialist in Multiple Sclerosis at the National MS Center in Melsbroek, Belgium.

Funding

This webinar was organized with the financial support of Sandoz.

Sandoz has not been involved in the elaboration of the presentations.